Literature DB >> 19178965

Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: a propensity-matched study of multimorbidity in chronic heart failure.

Christine Ritchie1, O James Ekundayo, Maureen Muchimba, Ruth C Campbell, Stuart J Frank, Bo Liu, Inmaculada B Aban, Ali Ahmed.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) and diabetes mellitus (DM) are common comorbidities in heart failure (HF) and each is associated with poor outcomes. However, the effects of multimorbidity related to having both CKD and DM compared to CKD alone have not been well studied in a propensity-matched population of chronic HF patients.
METHODS: Of the 7788 ambulatory chronic HF patients in the Digitalis Investigation Group trial, 3527 had CKD, of whom 1095 had DM. Based on the absence or presence of DM, patients were categorized CKD-only and CKD-DM, respectively. Propensity scores for CKD-DM were calculated for each patient and were used to match 987 pairs of CKD-only and CKD-DM patients. Hazard ratios (HR) and 95% confidence intervals (CI) comparing CKD-DM patients with CKD-only patients were estimated using matched Cox regression models.
RESULTS: All-cause mortality occurred in 47.0% (rate, 1783/10,000 person-years of follow-up) of CKD-DM patients and 39.6% (rate, 1414/10,000 person-years) of CKD-only patients (HR when CKD-DM is compared with CKD-only, 1.25; 95%-CI, 1.07-1.46; p=0.006). All-cause hospitalization occurred in 75.4% (rate, 5710/10,000 person-years) and 67.8% (rate, 4213/10,000 person-years) of CKD-DM and CKD-only patients respectively (HR, 1.32; 95%-CI, 1.15-1.52; p<0.0001). Respective HR and 95%-CI for other outcomes were: cardiovascular mortality (1.27; 1.06-1.52; p=0.009), HF mortality (1.34; 1.04-1.72; p=0.025); cardiovascular hospitalization (1.29; 1.12-1.49; p=0.001) and HF hospitalization (1.37; 1.16-1.63; p<0.0001).
CONCLUSIONS: Compared with comorbidity due to CKD alone, multimorbidity with CKD and DM was associated with poor outcomes in chronic HF patients.

Entities:  

Mesh:

Year:  2009        PMID: 19178965      PMCID: PMC2720313          DOI: 10.1016/j.ijcard.2008.12.089

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  17 in total

1.  Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores.

Authors:  S T Normand; M B Landrum; E Guadagnoli; J Z Ayanian; T J Ryan; P D Cleary; B J McNeil
Journal:  J Clin Epidemiol       Date:  2001-04       Impact factor: 6.437

2.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

3.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

4.  The effect of digoxin on mortality and morbidity in patients with heart failure.

Authors: 
Journal:  N Engl J Med       Date:  1997-02-20       Impact factor: 91.245

5.  Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure.

Authors: 
Journal:  Control Clin Trials       Date:  1996-02

6.  Role of diabetes in congestive heart failure: the Framingham study.

Authors:  W B Kannel; M Hjortland; W P Castelli
Journal:  Am J Cardiol       Date:  1974-07       Impact factor: 2.778

7.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

8.  Determination of vital status at the end of the DIG trial.

Authors:  Joseph F Collins; Cindy L Howell; R Anne Horney
Journal:  Control Clin Trials       Date:  2003-12

9.  Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus.

Authors:  Nagesh S Anavekar; Scott D Solomon; John J V McMurray; Aldo Maggioni; Jean Lucien Rouleau; Robert Califf; Harvey White; Lars Kober; Eric Velazquez; Marc A Pfeffer
Journal:  Am J Cardiol       Date:  2008-04-01       Impact factor: 2.778

Review 10.  Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart.

Authors:  Hoong Sern Lim; Robert J MacFadyen; Gregory Y H Lip
Journal:  Arch Intern Med       Date:  2004-09-13
View more
  14 in total

1.  Relationship between stage of kidney disease and incident heart failure in older adults.

Authors:  C Barrett Bowling; Margaret A Feller; Marjan Mujib; Pushkar P Pawar; Yan Zhang; O James Ekundayo; Inmaculada B Aban; Thomas E Love; Paul W Sanders; Stefan D Anker; Gregg C Fonarow; Ali Ahmed
Journal:  Am J Nephrol       Date:  2011-07-04       Impact factor: 3.754

2.  Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care.

Authors:  Bosco Baron-Franco; Gary McLean; Frances S Mair; Veronique L Roger; Bruce Guthrie; Stewart W Mercer
Journal:  Br J Gen Pract       Date:  2017-04-10       Impact factor: 5.386

3.  Informing clinical practice guideline development and implementation: prevalence of coexisting conditions among adults with coronary heart disease.

Authors:  Cynthia M Boyd; Bruce Leff; Jennifer L Wolff; Qilu Yu; Jing Zhou; Cynthia Rand; Carlos O Weiss
Journal:  J Am Geriatr Soc       Date:  2011-05       Impact factor: 5.562

4.  Neuroprotective properties of aucubin in diabetic rats and diabetic encephalopathy rats.

Authors:  Hong Yu Xue; Ya Nan Lu; Xue Mei Fang; Yong Ping Xu; Gui Zhen Gao; Li Ji Jin
Journal:  Mol Biol Rep       Date:  2012-07-19       Impact factor: 2.316

5.  Cardiovascular multimorbidity: the effect of ethnicity on prevalence and risk factor management.

Authors:  Rohini Mathur; Sally A Hull; Ellena Badrick; John Robson
Journal:  Br J Gen Pract       Date:  2011-05       Impact factor: 5.386

6.  Design and rationale of studies of neurohormonal blockade and outcomes in diastolic heart failure using OPTIMIZE-HF registry linked to Medicare data.

Authors:  Yan Zhang; Meredith L Kilgore; Tarun Arora; Marjan Mujib; O James Ekundayo; Inmaculada B Aban; Margaret A Feller; Ravi V Desai; Thomas E Love; Richard M Allman; Gregg C Fonarow; Ali Ahmed
Journal:  Int J Cardiol       Date:  2011-11-25       Impact factor: 4.164

7.  Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone.

Authors:  Phillip H Lam; Daniel J Dooley; Chakradhari Inampudi; Cherinne Arundel; Gregg C Fonarow; Javed Butler; Wen-Chih Wu; Marc R Blackman; Markus S Anker; Prakash Deedwania; Michel White; Sumanth D Prabhu; Charity J Morgan; Thomas E Love; Wilbert S Aronow; Richard M Allman; Ali Ahmed
Journal:  Int J Cardiol       Date:  2016-11-04       Impact factor: 4.164

8.  Gender-related dissociation in outcomes in chronic heart failure: reduced mortality but similar hospitalization in women.

Authors:  Mustafa I Ahmed; Mitja Lainscak; Marjan Mujib; Thomas E Love; Inmaculada Aban; Ileana L Piña; Wilbert S Aronow; Vera Bittner; Ali Ahmed
Journal:  Int J Cardiol       Date:  2009-11-24       Impact factor: 4.164

Review 9.  Peritoneal dialysis--current status and future challenges.

Authors:  Simon J Davies
Journal:  Nat Rev Nephrol       Date:  2013-05-21       Impact factor: 28.314

10.  Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study.

Authors:  Prakash Deedwania; Kanan Patel; Gregg C Fonarow; Ravi V Desai; Yan Zhang; Margaret A Feller; Fernando Ovalle; Thomas E Love; Inmaculada B Aban; Marjan Mujib; Mustafa I Ahmed; Stefan D Anker; Ali Ahmed
Journal:  Int J Cardiol       Date:  2013-05-31       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.